Botanical species · safety record

Amaryllis belladonna

The EFSA Compendium of Botanicals holds 8 constituent measurements for Amaryllis belladonna. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Amaryllis belladonna L.

8Constituent measurements

0Safety records

4Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Ambelline	Aerial part of plants	Solvent extraction	—	Unspecified	Resolve DOI
Caranine	Aerial part of plants	Solvent extraction	—	Unspecified	Resolve DOI
Isoquinoline alkaloids	Aerial part of plants	Solvent extraction	—	Unspecified	Resolve DOI
Lycorine	Aerial part of plants	Solvent extraction	—	Unspecified	Resolve DOI
Pratorimine	Aerial part of plants	Solvent extraction	—	Unspecified	Resolve DOI
Alkaloids	Bulb / clove	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Galanthamine	Bulb / clove	Solvent extraction	—	Unspecified	No resolvable identifier
Isoquinoline alkaloids	Bulb / clove	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Queckenberg, OR., Frahm, AW., MullerDoblies, D., MullerDoblies, U. Reinvestigation of Amaryllis belladonna. Phytochemical analysis, 1996, vol. 7, no. 3, p. 156-160.
Warnhoff, E. W. Belladine: a novel amaryllidaceae alkaloid. Chemistry & industry (london, united kingdom), 1957, p. 1385-6.
Nair, Jerald J., van Staden, Johannes. Pharmacological and toxicological insights to the South African Amaryllidaceae . Food and chemical toxicology, 2013, vol. 62, p. 262-275. DOI
Cherkasov, O. A. Plant sources of galanthamine. Khimiko-farmatsevticheskii zhurnal, 1977, vol. 11, no. 6, p. 84-7.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature